TABLE 1.
Demographic and clinical characteristics
| Characteristic | Values for: |
|
|---|---|---|
| NTM group (n = 51) | Non-NTM group (n = 211) | |
| No. (%) of females | 37 (72.5) | 157 (73.7) |
| Median (range) age (yr) | 65 (18–78) | 34 (18–75) |
| No. (%) of subjects by race | ||
| American Indian or Alaska Native | 1 (1.9) | 1 (0.5) |
| Asian | 13 (6.1) | |
| Black or African American | 2 (0.9) | |
| Multiracial | 1 (1.9) | 13 (6.1) |
| White | 49 (96.1) | 178 (83.6) |
| Unknown or not reported | 6 (2.8) | |
| No. (%) of subjects by Hispanic or Latino ethnicity | ||
| Hispanic or Latino | 1 (1.9) | 10 (4.7) |
| Not Hispanic or Latino | 50 (98.0) | 194 (91.9) |
| Unknown or not reported | 9 (4.3) | |
| No. (%) of subjects infected with the following NTM species: | ||
| M. avium-M. intracellulare | 46 (90.2) | |
| M. abscessus | 5 (9.8) | |
| No. (%) of subjects with the following comorbidities: | ||
| Lung cancer | 1 (2.0) | 1 (0.5) |
| Sjogren's syndrome | 1 (2.0) | 1 (0.5) |
| Type 2 diabetes | 1 (2.0) | 2 (0.9) |
| Gastrointestinal reflux disease | 8 (15.7) | 9 (4.3) |
| Inflammatory bowel disease | 1 (2.0) | 3 (1.4) |
| COPDa | 8 (15.7) | 2 (0.9) |
| Cystic fibrosis | 3 (5.9) | |
| Bronchiectasis | 35 (68.6) | |
| Rheumatoid arthritis | 3 (5.9) | |
a
COPD, chronic obstructive pulmonary disease.